The relationship between the BRAF(V600E) mutation in papillary thyroid microcarcinoma and clinicopathologic factors

BACKGROUND: The BRAF(V600E) mutation, which accounts for about 60–80% papillary thyroid carcinoma(PTC), has been identifiedas a prognostic marker for risk stratification of PTC patients. However, the BRAF(V600E) mutation as a prognostic marker in papillary thyroid microcarcinoma (PTMC) is unclear. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Sun Yi, Park, HeonSoo, Kang, Myung Koo, Lee, Dong Kun, Lee, Kang Dae, Lee, Hyoung Shin, Kim, Sung Won, Lee, Eun Nam, Hong, Jong Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833185/
https://www.ncbi.nlm.nih.gov/pubmed/24228637
http://dx.doi.org/10.1186/1477-7819-11-291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833185/
https://www.ncbi.nlm.nih.gov/pubmed/24228637
http://dx.doi.org/10.1186/1477-7819-11-291

Ejemplares similares